Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now early-phase tilt small index

MALT Lymphoma: early-phase trial registry

1 of 2 indexed MALT Lymphoma trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #7,188 of 28,707 conditions by registered trial count.

2 US clinical trials · 1 currently recruiting · #7,188 of 28,707 conditions by registered trial count

MALT Lymphoma: 2 US clinical trials tracked, 1 recruiting.

MALT Lymphoma is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Schrödinger, running 1 of these trials.

Enrollment posture brief

Registry condition malt-lymphoma

OPEN 1 | RECR 50% | LATE 0 | EARLY 2 | RANK #7188 | SPON 1

Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%MALT Lymphoma (this)50%
Open-enrollment share among volume-matched conditions near MALT Lymphoma

MALT Lymphoma lists 1 open slots (50% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for MALT Lymphoma on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. MALT Lymphoma is recruiting above its size-band peers.

    1 of 2 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 11Phase 21

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 2 1

Top Sponsors

Named interventions

Most-linked intervention names on MALT Lymphoma records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

SGR-1505 Drug
1 trials
Rituximab Drug
1 trials
Fludarabine Drug
1 trials

US sites by state

Facility locations filed on MALT Lymphoma trials. A trial with sites in several states counts in each.

New York 2 trials
Massachusetts 2 trials
Wisconsin 1 trials
Washington 1 trials
Texas 1 trials
Rhode Island 1 trials
Oregon 1 trials
Ohio 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this MALT Lymphoma page

2 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 MALT Lymphoma trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Schrödinger sponsors the most MALT Lymphoma trials on record, review their full trial history before evaluating a specific study. See Schrödinger's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This MALT Lymphoma condition card totals 2 registered trials; most-linked intervention SGR-1505; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.